Skip to main content

Howe & Rusling Inc

SEC CIK
0000769963
Latest filing
Aug 10, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Howe & Rusling Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
11,499
Value
$5.71M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Howe & Rusling Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,499$5.71M0.3%+1,778+18.3%AddedHolders
Q1 20269,721$4.34M0.3%+203+2.1%AddedHolders
Q4 20259,518$4.31M0.3%+168+1.8%AddedHolders
Q3 20259,350$3.66M0.3%−94−1.0%ReducedHolders
Q2 20259,444$4.20M0.3%+318+3.5%AddedHolders
Q1 20259,126$4.42M0.4%+232+2.6%AddedHolders
Q4 20248,894$3.58M0.3%−198−2.2%ReducedHolders
Q3 20249,092$4.23M0.4%+315+3.6%AddedHolders
Q2 20248,777$4.11M0.4%+640+7.9%AddedHolders
Q1 20248,137$3.40M0.3%+101+1.3%AddedHolders
Q4 20238,036$3.27M0.3%+292+3.8%AddedHolders
Q3 20237,744$2.69M0.3%−267−3.3%ReducedHolders
Q2 20238,011$2.82M0.3%−339−4.1%ReducedHolders
Q1 20238,350$2.63M0.3%−218−2.5%ReducedHolders
Q4 20228,568$2.47M0.3%−87−1.0%ReducedHolders
Q3 20228,655$2.51M0.3%+306+3.7%AddedHolders
Q2 20228,349$2.35M0.3%+54+0.7%AddedHolders
Q1 20228,295$2.17M0.3%−2,994−26.5%ReducedHolders
Q4 202111,289$2.48M0.3%−946−7.7%ReducedHolders
Q3 202112,235$2.22M0.3%−452−3.6%ReducedHolders
Q2 202112,687$2.56M0.3%+12,653+37,214.7%AddedHolders
Q1 202134$7.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.